NYSEAMERICAN:KNW Know Labs (KNW) Stock Forecast, Price & News $0.25 +0.02 (+8.70%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$0.23▼$0.2650-Day Range N/A52-Week Range$0.23▼$2.02Volume958,359 shsAverage Volume687,394 shsMarket Capitalization$13.09 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsInsider TradesHeadlinesShort InterestSocial MediaProfileChartCompetitorsEarningsInsider TradesHeadlinesShort InterestSocial Media About Know Labs (NYSEAMERICAN:KNW) StockKnow Labs, Inc. focuses on the development and commercialization of proprietary biosensor technologies in the United States. Its proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy along the electromagnetic spectrum to perform analytics. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is based in Seattle, Washington.Read More KNW Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart KNW Stock News HeadlinesSeptember 27, 2023 | news.yahoo.comClinic, lab expansion to get 'dirty'September 27, 2023 | benzinga.comWhy Know Labs (KNW) Stock Hit A New 52-Week Low TodayOctober 1, 2023 | Chaikin Analytics (Ad)Buy This Stock for AI Tidal Wave (not NVDA)The internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.September 27, 2023 | msn.comWhy Is Know Labs (KNW) Stock Down 37% Today?September 27, 2023 | finance.yahoo.comKnow Labs, Inc. Announces Pricing of $7 Million Public Offering of Common StockSeptember 11, 2023 | sfgate.comCT cannabis testing lab shuts down, leaving just one in stateSeptember 7, 2023 | msn.comLab in Willow Grove 1st in the world to identify new synthetic opioid more potent than fentanylSeptember 6, 2023 | msn.comLab in Willow Grove first in the world to identify new synthetic opioid more potent than fentanylOctober 1, 2023 | Behind the Markets (Ad)How A.I. Could Make Most 21st Century Diseases EXTINCTOn December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...August 22, 2023 | msn.com'More than just a job.' Literacy Lab expands opportunities for young Black men in CincinnatiAugust 19, 2023 | uk.finance.yahoo.comKnow Labs, Inc. (ASE:KNW) Q3 2023 Earnings Call TranscriptAugust 14, 2023 | finance.yahoo.comKnow Labs, Inc. Reports Third Quarter FY2023 ResultsAugust 3, 2023 | news.yahoo.comEndor Labs, which helps companies secure their open source packages, raises $70MAugust 3, 2023 | finance.yahoo.comKnow Labs, Inc. to Host Review of Third Quarter Fiscal Year 2023 Results on August 14, 2023July 26, 2023 | finance.yahoo.comKnow Labs Demonstrates Improved Accuracy of Machine Learning Model for Non-Invasive Glucose MonitorJuly 15, 2023 | msn.comCarolina lab begins testing for deadly drug labeled 'emerging threat' by the White HouseJune 12, 2023 | benzinga.comNo More Finger Pricks – Know Labs Is Developing A Completely Non-Invasive Blood Glucose MonitorJune 7, 2023 | finance.yahoo.comKnow Labs Completes Build of Portable Generation 1 Prototype for Non-Invasive Glucose MonitoringMay 25, 2023 | finanznachrichten.deStock Day Media: Know Labs, Inc. Discusses Significant Growth of Its IP Portfolio and 2023 Goals with The Stock Day PodcastMay 25, 2023 | finance.yahoo.comKnow Labs, Inc. Discusses Significant Growth of Its IP Portfolio and 2023 Goals with The Stock Day PodcastMay 18, 2023 | finance.yahoo.comKnow Labs Furthers External Validation of Bio-RFID™ Technology with Study Published in Sensors JournalMay 15, 2023 | finance.yahoo.comKnow Labs, Inc. Reports Second Quarter FY2023 ResultsMay 9, 2023 | news.yahoo.comDespite Oct. 2022 'groundbreaking,' state health lab lot still empty. When will construction start?May 8, 2023 | finance.yahoo.comKnow Labs, Inc. to Host Review of Second Quarter Fiscal Year 2023 Results on May 15, 2023May 5, 2023 | bizjournals.comInflux of cannabis testing labs could alleviate delays, but state still lags on capacityMay 5, 2023 | msn.comKCPD: Crime lab significantly reducing backlog of DNA samples to bring justice to victimsApril 25, 2023 | msn.comSC Labs Expands Its Cannabis Testing Services Into Arizona With The Acquisition Of C4See More Headlines Receive KNW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Know Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address KNW Company Calendar Last Earnings8/14/2023Today10/01/2023Next Earnings (Estimated)12/18/2023Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN Industry Measuring & controlling devices, not elsewhere classified Sub-IndustryN/A SectorBusiness Services Current SymbolNYSEAMERICAN:KNW CUSIPN/A CIKN/A Webwww.knowlabs.co Phone(206) 903-1351Fax206-826-0451Employees11Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.49) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-20,070,000.00 Net MarginsN/A Pretax Margin-205,966.66% Return on Equity-247.24% Return on Assets-143.87% Debt Debt-to-Equity RatioN/A Current Ratio1.06 Quick Ratio1.06 Sales & Book Value Annual Sales$4.36 million Price / Sales3.00 Cash FlowN/A Price / Cash FlowN/A Book Value$0.22 per share Price / Book1.14Miscellaneous Outstanding Shares52,360,000Free Float45,185,000Market Cap$13.09 million OptionableNot Optionable Beta1.66 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Ronald P. Erickson J.D. (Age 79)Founder, CEO, Treasurer & Chairman Comp: $474.48kMr. Peter Joseph ConleyCFO & Sr. VP of Intellectual PropertyMs. Jessica English (Age 37)Chief Marketing Officer Dr. James H. Anderson Jr.M.D., Chief Medical Officer and Chairman of Medical, Scientific & Regulatory Advisory BoardMr. Steven T. KentChief Product OfficerMr. Leonardo Trautwein (Age 41)Chief Commercial Officer More ExecutivesKey CompetitorsClearOneNASDAQ:CLROARC Group WorldwideOTCMKTS:ARCWSurge ComponentsOTCMKTS:SPRSBright Mountain MediaOTCMKTS:BMTMIntellineticsOTCMKTS:INLXView All CompetitorsInsiders & InstitutionsCitadel Advisors LLCSold 46,636 shares on 8/15/2023Ownership: 0.109%Geode Capital Management LLCBought 139,469 shares on 8/11/2023Ownership: 0.294%Callan Capital LLCBought 20,000 shares on 8/4/2023Ownership: 0.309%Patriot Financial Group Insurance Agency LLCBought 15,000 shares on 7/17/2023Ownership: 0.106%Ichiro John Paul TakesakoSold 8,500 sharesTotal: $7,395.00 ($0.87/share)View All Insider TransactionsView All Institutional Transactions KNW Stock - Frequently Asked Questions Are investors shorting Know Labs? Know Labs saw a decrease in short interest in the month of September. As of September 15th, there was short interest totaling 207,600 shares, a decrease of 16.2% from the August 31st total of 247,600 shares. Based on an average daily volume of 133,200 shares, the days-to-cover ratio is currently 1.6 days. Approximately 0.6% of the company's stock are sold short. View Know Labs' Short Interest. When is Know Labs' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, December 18th 2023. View our KNW earnings forecast. How were Know Labs' earnings last quarter? Know Labs, Inc. (NYSEAMERICAN:KNW) announced its earnings results on Monday, August, 14th. The company reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.02) by $0.06. What is Know Labs' stock symbol? Know Labs trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "KNW." How do I buy shares of Know Labs? Shares of KNW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Know Labs' stock price today? One share of KNW stock can currently be purchased for approximately $0.25. How much money does Know Labs make? Know Labs (NYSEAMERICAN:KNW) has a market capitalization of $13.09 million and generates $4.36 million in revenue each year. The company earns $-20,070,000.00 in net income (profit) each year or ($0.49) on an earnings per share basis. How can I contact Know Labs? Know Labs' mailing address is 500 UNION STREET SUITE 810, SEATTLE WA, 98101. The official website for the company is www.knowlabs.co. The company can be reached via phone at (206) 903-1351, via email at vsul@liolios.com, or via fax at 206-826-0451. This page (NYSEAMERICAN:KNW) was last updated on 10/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Know Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.